Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination Device

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Primary objective: To evaluate the safety and immunogenicity of low-dose ID S-OIV H1N1 vaccines delivered via a novel microneedle device (MicronJet600) and compare this to the full-dose standard IM injection. Hypothesis: Low dose (20%) intradermal (ID) S-OIV H1N1 vaccine delivered via a novel microneedle device (MicronJet600) is equally effective as full-dose standard intramuscular (IM) vaccine.
Epistemonikos ID: a24ad0e881bf78a5fa838e7e5274ce244015eba9
First added on: May 05, 2024